343 related articles for article (PubMed ID: 19854965)
1. Focused ultrasound microbubble destruction-mediated changes in blood-brain barrier permeability assessed by contrast-enhanced magnetic resonance imaging.
Wang F; Cheng Y; Mei J; Song Y; Yang YQ; Liu Y; Wang Z
J Ultrasound Med; 2009 Nov; 28(11):1501-9. PubMed ID: 19854965
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of drug delivery enhanced by acoustic pressure during blood-brain barrier disruption induced by focused ultrasound.
Yang FY; Lee PY
Int J Nanomedicine; 2012; 7():2573-82. PubMed ID: 22679368
[TBL] [Abstract][Full Text] [Related]
3. Static Magnetic Fields Dampen Focused Ultrasound-mediated Blood-Brain Barrier Opening.
Yang Y; Pacia CP; Ye D; Yue Y; Chien CY; Chen H
Radiology; 2021 Sep; 300(3):681-689. PubMed ID: 34227880
[TBL] [Abstract][Full Text] [Related]
4. Effects of transcranial ultrasound and intravenous microbubbles on blood brain barrier permeability in a large animal model.
Xie F; Boska MD; Lof J; Uberti MG; Tsutsui JM; Porter TR
Ultrasound Med Biol; 2008 Dec; 34(12):2028-34. PubMed ID: 18692294
[TBL] [Abstract][Full Text] [Related]
5. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.
Park J; Zhang Y; Vykhodtseva N; Jolesz FA; McDannold NJ
J Control Release; 2012 Aug; 162(1):134-42. PubMed ID: 22709590
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence imaging of Evans blue extravasation into mouse brain induced by low frequency ultrasound with microbubble.
Shen Y; Zhang A; Guo J; Dan G; Chen S; Yu H
Biomed Mater Eng; 2014; 24(6):2831-8. PubMed ID: 25226988
[TBL] [Abstract][Full Text] [Related]
7. Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation.
Yang FY; Lin YS; Kang KH; Chao TK
J Control Release; 2011 Feb; 150(1):111-6. PubMed ID: 21070825
[TBL] [Abstract][Full Text] [Related]
8. Microbubble type and distribution dependence of focused ultrasound-induced blood-brain barrier opening.
Wang S; Samiotaki G; Olumolade O; Feshitan JA; Konofagou EE
Ultrasound Med Biol; 2014 Jan; 40(1):130-7. PubMed ID: 24239362
[TBL] [Abstract][Full Text] [Related]
9. Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters.
Shin J; Kong C; Cho JS; Lee J; Koh CS; Yoon MS; Na YC; Chang WS; Chang JW
Neurosurg Focus; 2018 Feb; 44(2):E15. PubMed ID: 29385915
[TBL] [Abstract][Full Text] [Related]
10. Characterization of passive permeability after low intensity focused ultrasound mediated blood-brain barrier disruption in a preclinical model.
Arsiwala TA; Sprowls SA; Blethen KE; Fladeland RA; Wolford CP; Kielkowski BN; Glass MJ; Wang P; Wilson O; Carpenter JS; Ranjan M; Finomore V; Rezai A; Lockman PR
Fluids Barriers CNS; 2022 Sep; 19(1):72. PubMed ID: 36076213
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of dose distribution of molecular delivery after blood-brain barrier disruption by focused ultrasound with treatment planning.
Yang FY; Chen CC; Kao YH; Chen CL; Ko CE; Horng SC; Chen RC
Ultrasound Med Biol; 2013 Apr; 39(4):620-7. PubMed ID: 23384461
[TBL] [Abstract][Full Text] [Related]
12. Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound.
Mei J; Cheng Y; Song Y; Yang Y; Wang F; Liu Y; Wang Z
J Ultrasound Med; 2009 Jul; 28(7):871-80. PubMed ID: 19546329
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
14. Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model.
Horodyckid C; Canney M; Vignot A; Boisgard R; Drier A; Huberfeld G; François C; Prigent A; Santin MD; Adam C; Willer JC; Lafon C; Chapelon JY; Carpentier A
J Neurosurg; 2017 Apr; 126(4):1351-1361. PubMed ID: 27285538
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound enhanced delivery of macromolecular agents in brain tumor rat model.
Yang FY; Horng SC
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():5573-6. PubMed ID: 22255602
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption.
Yang FY; Fu WM; Yang RS; Liou HC; Kang KH; Lin WL
Ultrasound Med Biol; 2007 Sep; 33(9):1421-7. PubMed ID: 17561334
[TBL] [Abstract][Full Text] [Related]
17. Efficient Enhancement of Blood-Brain Barrier Permeability Using Acoustic Cluster Therapy (ACT).
Åslund AK; Snipstad S; Healey A; Kvåle S; Torp SH; Sontum PC; Davies CL; van Wamel A
Theranostics; 2017; 7(1):23-30. PubMed ID: 28042313
[TBL] [Abstract][Full Text] [Related]
18. Comparing rapid short-pulse to tone burst sonication sequences for focused ultrasound and microbubble-mediated blood-brain barrier permeability enhancement.
McMahon D; Deng L; Hynynen K
J Control Release; 2021 Jan; 329():696-705. PubMed ID: 33022327
[TBL] [Abstract][Full Text] [Related]
19. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
[TBL] [Abstract][Full Text] [Related]
20. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits.
McDannold N; Vykhodtseva N; Raymond S; Jolesz FA; Hynynen K
Ultrasound Med Biol; 2005 Nov; 31(11):1527-37. PubMed ID: 16286030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
